On April 1, 2026, the FDA approved Foundayo (orforglipron) from Eli Lillythe first oral small-molecule GLP-1 receptor agonist for chronic weight management
When you submit your inquiry regarding insurance coverage levels, our team will assist you in obtaining the information you need regarding your BCBS FEP health insurance coverage for your teens treatment
Clouses comments seemed to echo those given last week to Bloomberg by Kellanova CEO Steve Cahillane, whose company makes Pringles, Cheez-Its, and Rice Krispy Treats
Semaglutide essentially gives your body a head start on satiety, so you feel satisfied eating less food
NAD+ therapy may help support healthy aging, cognitive function, energy metabolism, and overall wellness as part of a personalized treatment plan
Biochemistry 50 (26), 58705882